Gsk Plc Portfolio Stock Holdings
According to the SEC 13F filed on August 13, 2026, Gsk Plc disclosed 11 stock positions valued at approximately $602.22M as of quarter-end June 30, 2026. The largest holdings include CRISPR THERAPEUTICS AG, VIR BIOTECHNOLOGY INC, and BIONTECH SE.
- Report Period
- June 30, 2026
- No. of Stocks
- 11
- Portfolio Value
- $602.22M
Holdings by Sector
Gsk Plc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| CRISPR THERAPEUTICS AG | CRSP | Other | 29.17% | 3,220,627 | - | - | $175,652,997 |
| VIR BIOTECHNOLOGY INC | VIR | Healthcare | 14.47% | 8,550,954 | - | - | $87,134,221 |
| BIONTECH SE | BNTX | Healthcare | 13.75% | 889,824 | - | - | $82,798,123 |
| IDEAYA BIOSCIENCES INC | IDYA | Healthcare | 8.25% | 1,333,333 | - | - | $49,693,321 |
| CYTOKINETICS INC | CYTK | Healthcare | 4.82% | 340,434 | - | - | $29,001,573 |
| SPERO THERAPEUTICS INC | SPRO | Healthcare | 3.37% | 9,190,606 | - | - | $20,311,239 |
| NKARTA INC | NKTX | Healthcare | 1.48% | 3,150,732 | - | - | $8,916,572 |
| FULCRUM THERAPEUTICS INC | FULC | Healthcare | 1.09% | 1,785,714 | - | - | $6,535,713 |
| BICYCLE THERAPEUTICS PLC | BCYC | Healthcare | 1.08% | 1,529,561 | - | - | $6,485,339 |
| CVRX INC | CVRX | Healthcare | 0.86% | 1,007,583 | - | - | $5,178,977 |
| REGENXBIO INC | RGNX | Healthcare | 0.54% | 271,456 | - | - | $3,252,043 |
Showing 11 of 11 holdings in the latest reporting period.